P eriodic limb movements in sleep (PLMS) is a disorder characterized by repetitive stereotypical movements of the legs during sleep, and has often been associated with fragmented sleep, symptoms of insomnia and excessive daytime sleepiness. 1 Defining PLMS based on a PLM index (PLMI = leg movements / hour of sleep) of 5 or greater, the prevalence has been estimated at 5%-6% of community-dwelling younger adults.
leg movements are defined and measured, with some, but not all, laboratories reporting all periodic leg movements independent of their association with cortical arousals.
This study determined the prevalence and severity of PLMS in a subset of older women participating in the Study of Osteoporotic Fractures (SOF). SOF is a large multi-center study begun in 1986 as a longitudinal study to assess risk factors of osteoporotic fractures in community-dwelling women. Measures of sleep were added to the latest visit cycle, which included PSG in a subset of 461 participants, 455 of whom had PLMS data. This study assessed whether: 1) increasing severity of PLMS was associated with objective evidence of poorer sleep quality and subjective daytime sleepiness; and 2) whether stronger associations were evident when PLMS was defined by leg movements associated with cortical arousals (PLMA) as compared to indices that included periodic leg movements (PLMI) without arousals.
METHODS

Participants
The sample was drawn from the SOF study, an ongoing cohort study that enrolled 9,704 Caucasian women between 1986 and 1988, and enrolled 662 African American women between 1997 and 1998. SOF inclusion criteria for study entry were that participants were community-dwelling, aged 65 years or older, able to walk unassisted, and had no previous bilateral hip replacement. They were recruited from population-based listings in four US areas: Baltimore County, Maryland; Minneapolis, Minnesota; Portland, Oregon; and the Monongahela Valley, near Pittsburgh, Pennsylvania. 10, 11 The most recent biannual visit (the 8th examination) is the focus of our analysis, in which objective and subjective measures of sleep were added to the protocol. The visit took place from 2002 to 2004. A total of 4,727 women participated in this visit (46% of the combined original study cohort). Of these, 3,137 visited a clinic for actigraphy, performance measures, anthropometry, and a clinic interview. One thousand fifty-one had questionnaire data only and 539 consented to a limited exam done in the home. Questionnaire information regarding sleep habits was asked of all women. Unattended overnight 12 channel inhome polysomnography was completed in a subset of 461 women recruited from 2 of the 4 clinical centers (Minnesota and Pittsburgh), with adequate PLMS data available for analysis in 455. The appropriate institutional review boards approved the study. Written consent was obtained from all participants.
Polysomnography (PSG)
PSG data were collected using the Compumedics Siesta Unit (Abbotsford, Victoria, AU), with monitoring of two central leads (C 1 , C 2 ) on electroencephalogram (EEG), bilateral electrooculogram (EOG), chin electromyogram (EMG), thoracic and abdominal respiratory effort, airflow (by a nasal-oral thermocouple and nasal pressure recording), finger pulse oximetry, electrocardiogram (ECG), body position, and bilateral leg movements with piezo sensors. Sleep data were scored by certified scorers. Sleep stages and arousals were scored using standard criteria, 12 without visualizing data on the respiratory or leg channels. Apneas were defined as a complete or almost complete cessation of airflow (by thermocouple) associated with ≥ 3% oxygen desaturation, and hypopneas were identified as a clearly discernible (at least 30%) reduction in respiratory sensor channels associated with a ≥ 3% oxygen desaturation. Leg movements were scored according to AASM criteria (≥ 4 consecutive 0.5 to 5 second movements, each separated by 5-90 seconds). 13 Leg movements that occurred at the termination of respiratory events were not considered in the calculation of PLMS unless they were part of a cluster of 4 or more leg movements in which at least 2 leg movements occurred independently of respiratory event termination.
PSG Indices
Sleep period was the time from reported lights off to morning awakening. Sleep stages were expressed as percentage of sleep time in each stage. Sleep efficiency was defined as the time asleep divided by the sleep period time. Arousals were scored according to AASM criteria. 14 The Arousal Index (ArI) was calculated as the number of arousals per hour of sleep. The apnea-hypopnea index (AHI) was defined as the mean number of respiratory events per hour of sleep. The AHI was examined continuously and using the cutpoints of ≥ 5 and ≥ 15. The periodic leg movements in sleep index (PLMI) was defined as the total number of leg movements (meeting the above criteria) per hour of sleep. Using software that linked each of the leg movements to the scored arousal data, PLMA was calculated as the total number of periodic leg movements in which EEG arousals occurred within 3 seconds of the termination of the leg movement. The PLMI and PLMA were examined both as continuous variables and in the categories < 5, 5 to < 15 and ≥ 15.
Other Measurements
All participants completed questionnaire data, which included questions about self-reported health and medical history. The Geriatric Depression Scale (GDS) was used to assess depressive symptoms, with the standard cutoff of 6 or more symptoms used to define depression. 15 Self-report information about daytime sleepiness was assessed using the Epworth Sleepiness Scale (ESS). 16 The standard cutpoint of ESS >10 was used to define excessive daytime sleepiness. 17 During the home or clinic visits body weight was measured with a standard balance beam scale, height with a wall-mounted Harpenden stadiometer (Holtain, England). Body mass index (BMI) was calculated as weight (kilograms) / height (meters 2 ). Also during the home or clinic visit the Mini-Mental State Examination (MMSE) was administered to assess cognitive function (range 0 to 30), with higher scores representing better cognitive functioning. 18 To assess function, women were asked whether they had difficulty performing any of 6 independent activities of daily living (IADL), which included walking 2-3 blocks, climbing or walking down 10 steps, preparing meals, performing heavy housework, and shopping. 19, 20 Participants were asked to bring in all medications used within the last 2 weeks, and a computerized medication coding dictionary was used to categorize the medications. 21 
Statistical Analysis
Characteristics and sleep outcomes were summarized using means and standard deviations (SD) for continuous data, counts and percentages for categorical data. We examined if subject characteristics were significantly different between the 455 wom-en in our analysis and those 4,272 who did not have PLMS data gathered. We also examined if subject characteristics and sleep parameters were associated with the categorical PLMS data. This was done using ANOVA for normally distributed continuous data, Kruskal-Wallis tests for skewed continuous data, and chi-squared test for categorical data.
Linear regression models were used to examine the relationships between the PLMS predictors and the continuous outcomes of sleep architecture, sleep efficiency and the arousal index. The distributions of sleep staging and the arousal index were skewed, so the data was transformed for normality. The arousal index was log-transformed. The transformation used for sleep staging was -log(-log[P+0.001]). Results are back-transformed for interpretation. Adjusted means and 95% confidence intervals (CI) for the categorical representations of our predictors were calculated using the least-squares means procedure. All models were adjusted for the confounders of age, race, BMI, antidepressant medication use, and AHI.
RESULTS
Participants
The sample had a mean age of 82.9 ± 3.5 years (29% ≥ 85 years), and 8% were African American. A comparison of the characteristics of this analytic sample to the remainder of the SOF population showed that the sample that participated in PSG studies was similar in regards to distribution of race, IADL impairment, depression, and medical conditions (Table 1 ) (all p>.05). The subset differed from the remaining cohort by age (younger by 1.3 years on average), BMI (higher by 1.1 kg/m 2 on average), education (0.3 years less educated on average), antidepressant medication use (11% compared to 15% in the remaining cohort) and cognitive functioning (higher by 0.7 points on average).
Distribution of Sleep Measures
For the 455 women in our analysis, the median arousal index (ArI) was 18.1 (interquartile range 12.0-26.3) and median sleep efficiency of 77.2% (interquartile range 67.1% to 83.9%). The median AHI was 11.3 (interquartile range 5.3-21.4) with 38% Data are mean ± standard deviation or N (% of the total n listed at top of column) *heart disease in defined as answering yes to "has a doctor ever told you that you have myocardial infarction, angina, congestive heart failure, or other heart disease?" † History of COPD is defined as answering yes to "has a doctor ever told you that you have chronic obstructive lung disease, chronic bronchitis, asthma, emphysema or COPD?" Data are mean ± standard deviation or N(% of the total n listed at top of column) Note: p-value comparing characteristic between PLMI categories. *heart disease in defined as answering yes to "has a doctor ever told you you have myocardial infarction, angina, congestive heart failure, or other heart disease?". †history of COPD is defined as answering yes to "has a doctor ever told you you had chronic obstructive lung disease, chronic bronchitis, asthma, emphysema, or COPD?". Table 2) .
Distribution of PLMI
The median PLMI for the entire sample was 16.8 (interquartile range 1.8 -46.6), with 301 participants (66%) showing a PLMI ≥ 5. Sixty-four (14%) participants had PLMI of 5 to < 15, and 237 (52%) participants had PLMI ≥ 15. As shown in Table 3 , an elevated PLMI was more frequent among women age ≥ 85 years than those 73 to 84 years (p=.01). A lower prevalence of African American ethnicity was found in those with elevated PLMI (p=.01). A higher PLMI was more frequently observed among individuals reporting antidepressant use(p=.002). Prevalence of comorbidities did not differ by PLMI category.
Association of PLMI with Sleep Measures
In unadjusted analyses, there were no significant associations between PLMI and ESS score, time in specific sleep stages or sleep efficiency. An elevated PLMI was associated with a higher ArI (p <.001) ( Table 4) .
Multivariable analyses were performed to determine if the unadjusted associations remained after controlling for age, race, BMI, antidepressant medication use, and AHI. Linear regression analyses showed that the adjusted association of PLMI and ArI was significant, with higher PLMI corresponding to higher ArI (adjusted means for ArI for PLMI<5: 15.4, PLMI 5 to 14.9: 18.2, PLMI ≥ 15: 19.4, p for trend <.0001). The adjusted associations between PLMI and sleep staging and sleep efficiency were not significant. Data are mean ± standard deviation or N(% of the total n listed at top of column) Note: p-value comparing characteristic between PLMA categories. *heart disease in defined as answering yes to "has a doctor ever told you you have myocardial infarction, angina, congestive heart failure, or other heart disease?". † history of COPD is defined as answering yes to "has a doctor ever told you you had chronic obstructive lung disease, chronic bronchitis, asthma, emphysema, or COPD?". Data are mean ± standard deviation or N(% of the total n listed at top of column) Note: p-value comparing characteristic between PLMI categories.
Distribution of PLMA
Distributions of PLMI and PLMA differed considerably (Figure 1) , but PLMI and PLMA were significantly correlated (r=0.86, p<.0001). The median PLMA was 1.9 (interquartile range 0.1-5.6). One hundred twenty-four participants (27%) had PLMA of ≥5, 98 (21.5%) participants had PLMA 5 to 14.9, and 26 (5.7%) participants had PLMA ≥ 15. Characteristics of participants by categories of PLMA are shown in Table 5 . A higher proportion of participants 85 years or older were found among those with elevated PLMA (p=.03). There was a trend for elevated PLMA to be associated with antidepressant use, but this association was not statistically significant (p=.15) ( Table 5) . No other subject characteristic, including comorbidities, differed by PLMA category.
Association of PLMA with Sleep Measures
In unadjusted analyses, participants with a higher PLMA had a shorter sleep period (p=.03), higher arousal index (p<.0001), and lower sleep efficiency (p<.001). In addition, those with elevated PLMA also had less REM sleep, more stages 1 and 2, and less stage 3-4 (p<.01) ( Table 6 ). There was no association between PLMA and ESS score.
Multivariable analyses were performed to determine if the unadjusted associations remained after controlling for age, race, BMI, antidepressant medication use, and AHI. After adjustment, a significant association of PLMA was observed for all sleep stages Data are mean ± standard deviation or N(% of the total n listed at top of column) Note: p-value comparing characteristic between PLMA categories. congestive heart failure, or other heart disease?". † history of COPD is defined as answering yes to "has a doctor ever told you you had chronic obstructive lung disease, chronic bronchitis, asthma, emphysema, or COPD?". (Table 7 ). Higher levels of PLMA corresponded to higher ArI and a higher percentage of time spent in sleep stages 1 and 2, and to a lower sleep efficiency and a lower percentage of time spent in sleep stages 3-4 and REM (p<.01).
DISCUSSION
The results of this study demonstrated a strong association between the number of periodic limb movements causing arousals per hour of sleep (PLMA) and poorer sleep quality as measured by PSG. In this cohort of community-dwelling older women, a higher PLMA was associated with shorter sleep duration, more frequent arousals, lower sleep efficiency, and a pattern of altered sleep stages suggesting lighter sleep (more stages 1 and 2 and less stages 3-4 and REM). In contrast, an elevated PLMI was only associated with increased ArI, and not associated with any other index of sleep continuity, sleepiness, or medical comorbidity. The results for both PLMI and PLMA demonstrate that PLMS is a common in older women. Specifically, a PLMI ≥ 5 was found in 73% of women aged ≥ 85 and 63% of women aged 73-84 years. Even using a more stringent criterion of PLMI ≥ 30, prevalences in these age groups were 49% and 35% respectively. These prevalence estimates using PLMI ≥ 5 are greater than previously reported estimates of 25%-58% in the literature, [3] [4] [5] [6] but lower than the 85% prevalence in Youngstedt's study of 22 elderly insomniac participants, 7 which may be partly due to the more advanced age and female sex of our participants.
PLMS was also common when based on the PLMA. Specifically, a PLMA ≥ 5 was found in 36% of women aged ≥ 85 and 24% of women aged 73-84. An elevated PLMA also showed strong associations with PSG markers of disrupted sleep. The consistent association of an elevated PLMA with markers of sleep disruption suggests that the PLMA may better discriminate older individuals with poorer sleep quality than the PLMI.
The results of this study support the hypothesis that PLMS increase with age. 24, 4 However, studies to date including the current study, have been cross-sectional, and the extent to which longitudinal changes in PLMS occur within aging subjects is unclear. The longitudinal data of Gehrman 3 in a small subset of the San Diego community cohort did not show an increase at 18 year follow-up, emphasizing the need for further longitudinal assessments to better determine the extent to which PLMS represent age-dependent pathophysiology.
Study participants, despite their advanced age, showed overall sleep stage distributions similar to those in other normative data. 22, 23 . The relatively preserved time in Stage 3-4 sleep is consistent with data from the Sleep Heart Health Study, where reduction in slow wave sleep with increased age was observed in men, but not in women. 22 Subjective sleepiness, as defined by an ESS >10, was present in only 11.4% of the cohort. The lack of an association of either the PLMI or PLMA with subjective sleepiness may be due to several factors, including the low prevalence of subjective sleepiness in the cohort, potential insensitivity of the ESS to daytime functional impairment in elderly populations, or the lack of significant contribution of PLMS to measurable subjective daytime symptoms in a population with a moderately high prevalence of impaired IADL.
In considering prevalence estimates for PLMS, it is important to note that the optimal criterion for diagnosing PLMS is unknown, as are the implications of using alternative sensors for quantifying frequency of leg movements. PLMS has been defined using cutoff values of both PLMI ≥5 25 and PLMI ≥15. 1 Since it is evident that leg movements increase with aging, it is likely that cutoff values may need to be modified to reflect the age distribution of the study sample. Our data indicate that a PLMI ≥5 was present in the majority of older women. Although the PLMI and PLMA were highly correlated, the frequency of leg movements associated with arousals was much lower. Thus, it is likely that alternative threshold values for identifying abnormality may need to be applied according to which definition of leg movements is utilized.
Our study had a number of strengths. It is larger than prior studies and includes detailed PSG-derived data. Our sample focused on an elderly female population in whom there has been only limited prior objective sleep data. The importance of understanding determinants and measurement issues related to sleep disturbances in older women is underscored by the high prevalence of subjective symptoms of sleep problems and the frequency of chronic comorbidities in this population. The sleep and leg movement data were objectively scored independently of one another by a group of highly trained scorers, providing reliable information that allowed various sleep indices to be independently compared. The sleep component of SOF was added long after the original recruitment, so there was less likelihood of recruitment bias for sleep symptoms. Further, while participants in the study were a consenting subset of SOF participants, they were similar to the remainder of the SOF cohort, supporting the generalizability of the findings to other community-based populations of older women. Our cross-sectional study had several limitations. Because our population consisted of older women, results cannot be generalized to men, younger people, or certain ethnic groups. Since we did not measure esophageal pressure, we could not exclude upper airway resistance events as a cause of PLMS. However, our scoring algorithm for leg movements explicitly excluded movement clusters that were exclusively associated with apneas or hypopneas, minimizing the likelihood that PLMS were a manifestation of sleep disordered breathing. In fact, there was a nonsignificant, negative correlation between the AHI with the PLMI and PLMA (r=-0.07 and -.02, respectively). In addition, our questionnaire did not include validated restless leg questions, which prevented analysis of the relationship between restless leg symptoms and PLMS. It is possible that the physiological impact of PLMS differs in subgroups with and without daytime symptoms of restless legs syndrome. Finally, leg movements were measured by piezo sensors, which are commonly used clinically, rather than by EMG. The optimal method for quantifying leg movements is an area of active investigation. In preliminary unpublished work using both piezo sensors and EMG electrodes, we observed similar patterns of PLMS. Nonetheless, the PLMS estimates we obtained may be most relevant to recording montages that utilize piezo sensors.
In summary, PLMS appear to be very common in the oldest old, with evidence suggesting a progressive increase in their prevalence with advancing age. An elevated PLMA was associated with a consistent pattern of sleep disruption, suggesting that periodic limb movements that cause EEG arousals are associated with objective evidence of poorer sleep than periodic limb movements that do not cause arousals. PLMS, defined using either the PLMI or PLMA, was not associated with daytime sleepiness or comorbidities. As the population continues to age, these results highlight the need for further research to better determine if there is a threshold level of the PLMA that identifies older participants at increased risk for comorbidity or functional limitations.
